Clinical Trial Update: STEM CELL MOBILIZATION WITH HIGH-DOSE PLERIXAFOR IN PATIENTS WITH SICKLE CELL DISEASE [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating high-dose plerixafor for stem cell mobilization in patients with sickle cell disease is not yet recruiting. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Mozobil (plerixafor)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING